Explanation:
Archaea were initially classified as bacteria, receiving the name archaebacteria (in the Archaebacteria kingdom), but this term has fallen out of use. Archaeal cells have unique properties separating them from the other two domains, Bacteria and Eukaryota. Archaea are further divided into multiple recognized phyla
Answer:
<u><em>Galapagos finches</em></u><u> have various beak sizes that make foraging for food more successful.</u>
Explanation:
Organisms evolve over time due to changes in their genome. These are pontaneous, and occur in DNA at random. These changes are called mutations and form alleles or different forms of a gene.
Over time within a population, the number alleles increase the variation of the population. These variants may confer specific traits within an individual, that may confer a biological advantage.
Thus, the trait may make the organisms more capable of obtaining food, shelter a mate etc. or ensure survival, i.e. they are able to pass on their genes to the next generation.
Plant uptake is the process which converts inorganic phosphorus in a rock to an organic form of phosphorus.
Answer:
In an ecosystem photosynthetic plants act as producers wheres other organism act as consumers.
Explanation:
Green plants undergo photosynthesis to produce their own food as a result they are called producers and are placed in the first tropic label of energy pyramid.
The other organism that intake green plants are called primary consumers for example grasshopper. The primary consumers are placed in the second tropic label of energy pyramid.
The other consumers are termed as secondary consumers or primary carnivores that feed on primary consumers For example Snake because it eats grasshopper and is placed in the third tropic label.
Finally the tertiary consumers or secondary carnivores consumes secondary consumers to intake energy from them.For example Hawk eats snake,as a result hawk act as secondary carnivores and are placed in the top of the energy pyramid.
Stem cell therapies are not new. Doctors have been performing bone marrow stem cell transplants for decades. But when scientists learned how to remove stem cells from human embryos in 1998, both excitement and controversy ensued.
The excitement was due to the huge potential these cells have in curing human disease. The controversy centered on the moral implications of destroying human embryos. Political leaders began to debate over how to regulate and fund research involving human embryonic stem (hES) cells.
Newer breakthroughs may bring this debate to an end. In 2006 scientists learned how to stimulate a patient's own cells to behave like embryonic stem cells. These cells are reducing the need for human embryos in research and opening up exciting new possibilities for stem cell therapies.
